跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAIVOBET - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
DAIVOBET
Approved
STANDARD
DAIVOBET
Leo Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9c33ff11e0c86d70
Company
Leo Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
9c33ff11e0c86d70
Drug Approval Philippines Name
DAIVOBET
Product Name
DAIVOBET
Registration Number
DR-XY41745
Brand Name
DAIVOBET
Generic Name
Calcipotriol (as Monohydrate) + Betamethasone (as dipropionate)
Dosage Form
Topical Gel
Dosage Strength
50 mcg/500 mcg per gram
Manufacturer
Leo Laboratories Ltd.
Importer
Getz Bros. Philippines, Inc.
Distributor
Getz Bros. Philippines, Inc.
Company Detail Path
/organization/leo-laboratories-ltd
Issuance Date
27 October 2024
Expiry Date
21 January 2030
Pharmacologic Category
Anti-psoriais
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9c33ff11e0c86d70
Type
Standard
Back to Philippines FDA Approvals